Skip to content

AngioDynamics ANGO EV / EBITDA

EV / EBITDA at other companies

Abbott logo
AbbottABT
18.9×-4.1×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
12.3×-6.5×
TFX
TeleflexTFX
26.8×+7.6×
Stryker logo
StrykerSYK
22.1×-11.8×
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.2×-10.5×
ICU Medical logo
ICU MedicalICUI
17.4×+0.4×

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

Based on the most recent quarter.

The official record: AngioDynamics’s 10-Q, filed January 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's EV / EBITDA?
AngioDynamics (ANGO) reported EV / EBITDA of 9.7× in Q3 2023.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.